Kathy’s presentation ‘Utilizing Clinical Supply Forecasting to Incorporate Efficiency and Flexibility in Supply Chain Management’ covered:

• Using clinical forecasting to select the optimal supply plan
• Preparing and planning for flexibility
  - Identifying options for increasing flexibility while still managing efficiency
  - Forecasting supply distribution to provide maximum flexibility
• Executing the clinical trial
  - Verifying and adapting the supply forecast
  - Interim analysis: what changes are likely to occur and when?
  - Determining the cost of flexibility
• Case studies showing how supply forecasting and flexibility improved the trial outcome

For further information on this Exl Pharma conference please visit: http://www.exlpharma.com/eventDetail.php?id=110

Tessella also exhibited at the conference as well as launching and demonstrating the Tessella Supply Forecasting Tool (SFT) developed in collaboration with UBC. SFT allows users to model the clinical supply chain efficiently and effectively.

If you were unable to join us at the conference but would like further information on supply forecasting and/or SFT please click here, email info@tessella.com or call the Marketing Department on +44 (0) 1235 555511.

Kathy Reinold, Tessella’s Clinical Technologies Product Manager, explained: “The efficient management of clinical trials continues to be a major focus for drug development companies. To ensure adequate drug supply at hundreds of sites, drug supply managers almost require a crystal ball. They have to cope with different customs regulations, shipping companies and delivery times, and provide instructions in multiple languages. In addition, they must predict the number of subjects that will be recruited onto the trial (and predict the treatment groups to which they will be assigned), predict the number of subjects in each treatment group that will drop out of the study, and predict delivery delays, loss of supply due to damage in transit, and more. At Tessella, we have applied our extensive experience solving complex problems, and our advanced statistical modeling expertise, to addressing these needs, and have co-developed with our first client UBC the Tessella Supply Forecasting Tool to provide drug supply managers with that illusive crystal ball.”

Tom Parke, Tessella’s Head of Clinical Trials Solutions, continued: “Tessella SFT provides an intuitive, easy-to-use interface, and the capability to import data, lists of centers, standard shipping times, etc, to allow the rapid development of drug supply plans. The tool’s advanced modeling of events, and simulation of the clinical supply chain, predicts how well a particular drug supply plan is likely to perform. Adopting SFT across an organization facilitates the sharing of expertise and encourages standardized techniques providing for more consistent drug supply management.”

Key features of Tessella SFT include: an easy-to-use interface; accurate forecasting; adjustable re-supply algorithms; comprehensive coverage of factors that affect supply; support for site-based, central, stratified and adaptive randomization; user-defined report generation; and simple integration through standard XML interfaces. The tool is also highly customizable.

Grant Stephen, CEO of Tessella Inc added: “The future of drug supply management will not become less complex, but tools that model the supply chain and trial events and perform hundreds of simulations can make the task more manageable. Tessella has been a leading independent supplier of custom-built software solutions to the pharma and biotech communities for many years, priding ourselves on understanding our clients’ business and technical requirements, and working with them to provide innovative solutions. We are delighted to now be fully supporting the drug supply managers.”

Further information on the Tessella Supply Forecasting Tool, plus views on situations where it is likely to be a strong option, can be obtained by emailing info@tessella.com.

- ends -

• For press enquiries or to arrange an interview with Tessella please email Alison Smith (Alison.Smith@tessella.com)
• Founded in 1980, Tessella specializes in the application of innovative solutions to scientific, technical and engineering problems, and its offices within the US, UK, and the Netherlands have built long-term relationships with organizations at the leading edge of the scientific and engineering world
• Tessella’s life sciences expertise spans: Clinical Trials technologies, Informatics & Knowledge Exploitation, ‘Omics Data Management & Analysis, Laboratory Automation & Workflows, Biomarkers & Systems Biology, PK/PD Modeling, Toxicity Modeling, Drug Formulation & Delivery Modeling, and Portfolio Management
• Tessella’s services include software design, development and support, mathematical modeling & simulation, algorithm development, project management and consultancy
• Co-sponsored by Tessella, the ExL Pharma Clinical Supply Forecasting Summit (28-29 April 2008, Philadelphia) aims to help delegates “reduce costs, increase performance and mitigate risk by optimizing the demand management of clinical supplies”. Speakers include Kathy Reinold, Tessella’s Clinical Technologies Product Manager, presenting on ‘Utilizing Clinical Supply Forecasting to Incorporate Efficiency and Flexibility in Supply Chain Management’. For further information on the Summit please visit: www.exlpharma.com/eventDetail.php?id=110

Tessella contact details:

Tessella Inc
233 Needham Street, Suite 300
Newton, MA 02464
USA
Tel: (1) 617 454 1220, Fax: (1) 617 454 1001
Tessella Inc also has an office in Washington DC

Tessella Support Services plc (Headquarters)
3 Vineyard Chambers
Abingdon
Oxfordshire, OX14 3PX
UK
Tel: +44 (0) 1235 555511, Fax: +44 (0) 1235 553301
Tessella also has UK offices in Burton upon Trent, Cambridge, Stevenage, Warrington and Winchester.

Tessella Support Services plc
Tauro Kantorencentrum
President Kennedylaan 19
2517JK Den Haag
the Netherlands
Tel/Fax: +31 (0) 70 354 2296

info@tessella.com